Patents by Inventor Jeffery A. Hooke

Jeffery A. Hooke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROTEIN MARKERS FOR ESTROGEN RECEPTOR (ER)-POSITIVE LUMINAL A (LA)-LIKE AND LUMINAL B1 (LB1)-LIKE BREAST CANCER
    Publication number: 20240402177
    Abstract: The present invention relates to protein markers for luminal A (LA)-like and luminal B1 (LB 1)-like breast cancer. Methods for differentiating LA-like and LB 1-like breast cancer in a ER-positive breast cancer subject are provided, such methods including the detection of levels of a variety of biomarkers for LA-like and LB 1-like breast cancer. Compositions in the form of kits and panels of reagents for detecting the biomarkers of the invention are also provided.
    Type: Application
    Filed: April 6, 2022
    Publication date: December 5, 2024
    Inventors: Michael Andrew Kiebish, Albert John Kovatich, Punit Shah, Niven Rajin Narain, Rangaprasad Sarangarajan, Guisong Wang, Jeffery A. Hooke, Hai Hu, Jamie Leigh Campbell, Mary L. Cutler, Craig D. Shriver
  • PROTEIN MARKERS FOR THE PROGNOSIS OF BREAST CANCER PROGRESSION
    Publication number: 20240230651
    Abstract: Methods for prognosing the risk of progression in a ER-positive breast cancer (e.g., luminal B 1 breast cancer) subject are provided, such methods including the detection of levels of a variety of biomarkers prognostic of progression. Compositions in the form of kits and panels of reagents for detecting the biomarkers of the invention are also provided.
    Type: Application
    Filed: April 6, 2022
    Publication date: July 11, 2024
    Inventors: Michael Andrew Kiebish, Albert John Kovatich, Punit Shah, Niven Rajin Narain, Rangaprasad Sarangarajan, Guisong Wang, Jeffery A. Hooke, Hai Hu, Jamie Leigh Campbell, Mary L. Cutler, Craig D. Shriver
  • PROTEIN MARKERS FOR ESTROGEN RECEPTOR (ER)-POSITIVE-LIKE AND ESTROGEN RECEPTOR (ER)-NEGATIVE-LIKE BREAST CANCER
    Publication number: 20230059578
    Abstract: The present invention relates to protein markers for ER-positive-like and ER-negative-like breast cancer. Methods for differentiating ER-positive-like and ER-negative-like breast cancer in a subject having breast cancer are provided, such methods including the detection of levels of a variety of biomarkers for ER-positive-like and ER-negative-like breast cancer. Compositions in the form of kits and panels of reagents for detecting the biomarkers of the invention are also provided.
    Type: Application
    Filed: April 6, 2022
    Publication date: February 23, 2023
    Inventors: Michael Andrew Kiebish, Albert John Kovatich, Punit Shah, Niven Rajin Narain, Rangaprasad Sarangarajan, Guisong Wang, Jeffery A. Hooke, Jamie Leigh Campbell, Mary Lou Cutler, Craig D. Shriver, Hai Hu